PL
JNJ icon

Pluribus Labs’s Johnson & Johnson JNJ Stock Holding History

Pluribus Labs’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$832K Buy
4,687
+1,530
+48% +$273K 1.52% 15
2022
Q1 		$560K Sell
3,157
-3,800
-55% -$647K 2.23% 8
2021
Q4 		$1.19M Buy
+6,957
New +$1.14M 1.26% 5

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pluribus Labs's JNJ Position: Q2 2022 in Review

Pluribus Labs increased its Johnson & Johnson (JNJ) stake by 48% in Q2 2022, buying an estimated $273K and bringing the position to 4,687 shares worth $832K. The position accounts for 1.52% of the portfolio, ranked #15.

Pluribus Labs first reported a position in JNJ in Q4 2021 and has held it in 3 quarters since. The position peaked at $1.19M in Q4 2021. 3,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

  • Pluribus Labs held 4,687 shares of Johnson & Johnson worth $832K as of Q2 2022.
  • Pluribus Labs bought 1,530 Johnson & Johnson shares in Q2 2022, an estimated $273K.
  • Johnson & Johnson made up 1.52% of Pluribus Labs's portfolio in Q2 2022, its #15 holding.
  • Pluribus Labs first reported a position in Johnson & Johnson in Q4 2021 and has held it in 3 quarters since.
  • Pluribus Labs's Johnson & Johnson position peaked at $1.19M in Q4 2021.
  • 3,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.